Patents by Inventor Claus Juul-Mortensen

Claus Juul-Mortensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stabilized pharmaceutical peptide compositions
    Patent number: 8614181
    Abstract: Method for increasing the shelf-life of a pharmaceutical composition for parenteral administration comprising a glucagon-like peptide which is prepared from a peptide product that has been subjected to treatment at a pH above neutral pH.
    Type: Grant
    Filed: November 5, 2009
    Date of Patent: December 24, 2013
    Assignee: Novo Nordisk A/S
    Inventors: Claus Juul-Mortensen, Dorte Kot Engelund
  • Dry mouldable drug formulation
    Patent number: 8518430
    Abstract: Solid pharmaceutical compositions for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.
    Type: Grant
    Filed: October 31, 2011
    Date of Patent: August 27, 2013
    Assignee: Novo Nordisk A/S
    Inventors: Thomas Buch-Rasmussen, James M. Flink, Jens Ulrich Poulsen, Søren Aasmul, Philip Hansen, Claus Juul Mortensen
  • DRY MOULDABLE DRUG FORMULATION
    Publication number: 20120082724
    Abstract: Solid pharmaceutical compositions for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.
    Type: Application
    Filed: October 31, 2011
    Publication date: April 5, 2012
    Applicant: Novo Nordisk A/S
    Inventors: THOMAS BUCH-RASMUSSEN, Søren Aasmul, James M. Flink, Philip Hansen, Jens Ulrik Poulsen, Claus Juul-Mortensen
  • Stabilized pharmaceutical peptide compositions
    Patent number: 8114959
    Abstract: Method for increasing the shelf-life of a pharmaceutical composition comprising a glucagon-like peptide which is prepared from a peptide product that has been dried at a pH above neutral pH.
    Type: Grant
    Filed: August 1, 2008
    Date of Patent: February 14, 2012
    Assignee: Novo Nordisk A/S
    Inventor: Claus Juul-Mortensen
  • Dry mouldable drug formulation
    Patent number: 8084053
    Abstract: Solid pharmaceutical compositions and methods of making and administering for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.
    Type: Grant
    Filed: August 7, 2009
    Date of Patent: December 27, 2011
    Assignee: Novo Nordisk A/S
    Inventors: Thomas Buch-Rasmussen, James M. Flink, Jens Ulrich Poulsen, Søren Aasmul, Philip Hansen, Claus Juul Mortensen
  • Stabilized Pharmaceutical Peptide Compositions
    Publication number: 20100056451
    Abstract: Method for increasing the shelf-life of a pharmaceutical composition for parenteral administration comprising a glucagon-like peptide which is prepared from a peptide product that has been subjected to treatment at a pH above neutral pH.
    Type: Application
    Filed: November 5, 2009
    Publication date: March 4, 2010
    Applicant: NOVO NORDISK A/S
    Inventors: CLAUS JUUL-MORTENSEN, DORTE KOT ENGELUND
  • Dry mouldable drug formulation
    Patent number: 7666844
    Abstract: Solid pharmaceutical compositions for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.
    Type: Grant
    Filed: February 7, 2005
    Date of Patent: February 23, 2010
    Assignee: Novo Nordisk A/S
    Inventors: Thomas Buch-Rasmussen, James M. Flink, Jens Ulrich Poulsen, Søren Aasmul, Philip Hansen, Claus Juul Mortensen
  • Stabilized pharmaceutical peptide compositions
    Patent number: 7632806
    Abstract: A method is disclosed for increasing the shelf-life of a pharmaceutical composition for parenteral administration comprising a glucagon-like peptide which is prepared from a peptide product that has been subjected to treatment at a pH above neutral pH.
    Type: Grant
    Filed: November 30, 2005
    Date of Patent: December 15, 2009
    Assignee: Novo Nordisk A/S
    Inventors: Claus Juul-Mortensen, Dorte Kot Engelund
  • Stabilized Pharmaceutical Peptide Compositions
    Publication number: 20080318865
    Abstract: Method for increasing the shelf-life of a pharmaceutical composition comprising a glucagon-like peptide which is prepared from a peptide product that has been dried at a pH above neutral pH.
    Type: Application
    Filed: August 1, 2008
    Publication date: December 25, 2008
    Applicant: Novo Nordisk A/S
    Inventor: Claus Juul-Mortensen
  • Stabilized pharmaceutical peptide compositions
    Publication number: 20060183682
    Abstract: Method for increasing the shelf-life of a pharmaceutical composition comprising a glucagon-like peptide which is prepared from a peptide product that has been dried at a pH above neutral pH.
    Type: Application
    Filed: November 30, 2005
    Publication date: August 17, 2006
    Applicant: Novo Nordisk A/S
    Inventor: Claus Juul-Mortensen
  • Stabilized pharmaceutical peptide compositions
    Publication number: 20060178304
    Abstract: Method for increasing the shelf-life of a pharmaceutical composition for parenteral administration comprising a glucagon-like peptide which is prepared from a peptide product that has been subjected to treatment at a pH above neutral pH.
    Type: Application
    Filed: November 30, 2005
    Publication date: August 10, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Claus Juul-Mortensen, Dorte Engelund
  • Dry mouldable drug formulation
    Publication number: 20050202072
    Abstract: Solid pharmaceutical compositions for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.
    Type: Application
    Filed: February 7, 2005
    Publication date: September 15, 2005
    Applicant: Novo Nordisk A/S
    Inventors: Thomas Buch-Rasmussen, Soren Aasmul, James Flink, Philip Hansen, Jens Poulsen, Claus Juul-Mortensen
  • Method for producing an elongated drug formation
    Patent number: 6660197
    Abstract: The present invention relates to a method and a system for producing an elongated drug formulation being suitable for being injected through the skin of a patient with-out the use of a needle or a cannula. The drug formulation is produced by compressing a drug granulate in cavity of a system comprising a roller and a surface, wherein the roller roles over the surface thereby comprising the granulate to the formulation.
    Type: Grant
    Filed: October 12, 2000
    Date of Patent: December 9, 2003
    Assignee: Novo Nordisk A/S
    Inventors: Thomas Buch-Rasmussen, Søren Aasmul, James M. Flink, Philip Hansen, Claus Juul-Mortensen, Jens-Ulrik Poulsen
  • Cassette for storing and insertion of solid medicine
    Patent number: 6485453
    Abstract: A cassette for storing and insertion of a solid medicine peg appears as a unit having a first bore (2) which accommodates the medicine peg (3) and has a diameter corresponding to the diameter of this peg (3), a second bore (4) in coaxial extension of the first bore (2) and having a diameter larger than the diameter of the first bore (2), an inserter having a shaft (5) fitting into the first bore (2) and a guiding head (6) in coaxial extension of the shaft (5) fitting into the second bore. The inserter shaft (5) has one end adjacent to the peg (3) and the other connected to the guiding head (6) which projects from the cassette. The head (6) fits into the second bore with a fitting providing a diffusion tight sealing and the distal end of the unit is closed by a membrane diffusion tightly sealing this distal end.
    Type: Grant
    Filed: April 13, 2000
    Date of Patent: November 26, 2002
    Assignee: Novo Nordisk A/S
    Inventors: Thomas Buch-Rasmussen, Søren Aasmul, James M. Flink, Philip Hansen, Claus Juul-Mortensen, Jens Ulrik Poulsen